Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: history of present illness: this patient is a 70-year-old male with extensive locally recurrent melanoma involving his face, status post excision, neck dissection and radiation therapy. initial staging was consistent with stage iii c disease but now with mets to the lung, bone and soft tissue. he was due to be started on high-dose il-2 but in clinic on , he was noticed to have erythema in an area of recent lymph node dissection felt consistent with cellulitis, and was started on oral keflex, and now is presenting with worsening erythema. the patient reports that in the week since he started antibiotics, the erythema has enlarged and become more red. in clinic today, his white blood cell count was up to 20,000 and he was admitted to omed service. past medical history: hypertension, metastatic melanoma with original diagnosis in . on he underwent wide local excision and sentinel lymph node biopsy, with melanoma present in 1 left intraparotid node. on he had re-excision of the left temple and cheek area and a left radical neck dissection, with melanoma in 7 of 69 total lymph nodes. he underwent radiation therapy to the forehead area, completing 20 fractions over 4 weeks. he then developed soft tissue nodule superior to the graft, that might have represented residual melanoma and appeared to have reduced in size with radiation. in late a pet ct showed increased glucose uptake at sites of surgery on his thigh and around the superior edge of the graft on his face. he was seen in follow-up one of three weeks after completion of radiation. follow up head mri and torso ct on revealed no metastatic brain lesions, but metastatic disease in his chest, left axilla, mediastinum and lung, as well as a t12 sclerotic focus felt consistent with melanoma. the brca mutation testing on his tumor was negative. he has passed screening tests to begin high-dose il-2 therapy. allergies: no known drug allergies. medications on admission: enalapril 20 mg p.o. daily, pravastatin 20 mg p.o. daily, keflex 500 mg p.o. b.i.d. physical examination on admission: reveals an elderly male in no apparent distress. heent: pupils equal, round, reactive to light. left temporal and buccal graft without erythema. neck: well-healed scar from posterior auricular area to the left upper chest. no signs of wound dehiscence. broad area of erythema and corresponding area warm to touch. no palpable masses or fluid collections. no cervical, supraclavicular or axillary lymphadenopathy. heart: regular rate and rhythm, s1, s2. chest: no dullness to percussion and clear to auscultation bilaterally. abdomen: positive bowel sounds, soft, nontender. extremities: warm and well perfused, 1+ edema to the way up shins bilaterally, 2+ dp and pt pulses. neurologic exam: nonfocal. admission labs: wbc 20.9, hemoglobin 11.7, hematocrit 33.7, platelet count 206,000, bun 20, creatinine 1.2, sodium 134, potassium 6.1, chloride 101, co2 23, glucose 117. hospital course: the patient was admitted with cellulitis and was placed on iv vancomycin. doxycycline was added when he did not appear to be improving. unasyn was added when the cellulitic area continued to worsen. he also became short of breath and was treated with lasix. transthoracic echo revealed diastolic heart failure and he was continued on enalapril and lasix. he had an id consult on who suggested stopping the unasyn, changing to cefepime and adding vancomycin back. blood cultures remained negative and he was afebrile throughout this time. derm consult on was obtained due to persistent rash, and a biopsy was performed consistent with melanoma. he was subsequently transferred to the biologic service on to begin high-dose il-2 therapy. during this week he received 7 of 14 doses with 7 doses held related to tachycardia and pulmonary edema. on treatment day #4, he was tachypneic with hypoxia to the mid 80s. chest x- ray was consistent with bilateral pleural effusions. throughout the day he became increasingly more tachypneic and fatigued, and was transferred to the icu. he was treated with lasix with improvement in his respiratory status. an echocardiogram on showed a small pericardial effusion with question tamponade physiology. cardiology was consulted and felt they were not able to tap the effusion. he underwent a cardiac mri on revealing no cardiac metastases and no tamponade physiology. he developed svt to the 140s on , which spontaneously improved with a fluid bolus. his respiratory status improved with continued diuresis, and he was transferred back to the floor on . lasix and enalapril were continued and he was weaned to room air with o2 saturations in the mid 90s. physical therapy consult was initiated and he was ambulating short distances with a steady gait. he was discharged to home on with a plan to follow up in clinic on . other side effects related to il-2 included rigors improved with demerol; fatigue; and hypotension on treatment day 3, requiring fluid boluses. during this week he developed acute renal failure with a peak creatinine of 3.0 with associated oliguria. he developed metabolic acidosis with a minimum bicarb of 18, improved with bicarbonate boluses. electrolytes were monitored and repleted per protocol. strict i & os and serum chemistries were maintained. iv fluids were continued given acute renal failure. during this week he had mild st elevation to 54, which improved prior to discharge. he had no hyperbilirubinemia, myocarditis or coagulopathy noted. he was thrombocytopenic to a platelet count low of 68,000 without evidence of bleeding. he was anemic and was transfused with packed red blood cells with discharge hemoglobin of 9.1. by he had recovered from side effects to allow for discharge to home. condition on discharge: alert, oriented and ambulatory. discharge status: to home with his family. discharge diagnoses: 1. metastatic melanoma status post cycle 1, week 1, high- dose il-2 therapy complicated by pulmonary edema, and bilateral pleural effusions from il-2 induced capillary leak, with respiratory distress. 2. acute renal failure related to il-2 therapy. discharge medications: enalapril 20 mg p.o. daily, lasix 20 mg p.o. daily, lorazepam 0.5 mg q. 6 hours p.r.n. nausea, pravastatin 20 mg p.o. daily, compazine 5 to 10 mg q.i.d. p.r.n. nausea. follow-up plans: the patient will return to clinic on for assessment of his clinical status prior to consideration for treatment with week #2 of therapy. i have reviewed the discharge summary and agree with the hospital course and disposition as dictated by . , md dictated by: medquist36 d: 12:32:55 t: 15:33:12 job#: procedure: venous catheterization, not elsewhere classified arterial catheterization closed biopsy of skin and subcutaneous tissue high-dose infusion interleukin-2 [il-2] central venous catheter placement with guidance diagnoses: acidosis unspecified pleural effusion congestive heart failure, unspecified acute kidney failure, unspecified unspecified disease of pericardium antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of skin secondary malignant neoplasm of lung acute diastolic heart failure secondary and unspecified malignant neoplasm of intrathoracic lymph nodes secondary malignant neoplasm of bone and bone marrow secondary and unspecified malignant neoplasm of lymph nodes of head, face, and neck cardiac tamponade unspecified hypertensive heart disease with heart failure secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb other secondary thrombocytopenia malignant melanoma of skin of other and unspecified parts of face 

Answer: The patient is high likely exposed to